V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260009184 | 260005995 | 1.52 | 51 | Palliative (P) | 2016-05-24 | 2016-05-24 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 260029371 | RITUXIMAB |
| 260009185 | 260005996 | 1.56 | 166 | Curative (C) | 2017-04-23 | 2017-04-29 | Rituximab | N | N | 260029374 | ECX |
| 260009186 | 260005996 | 1.73 | null | Palliative (P) | 2014-09-21 | 2014-09-28 | Rituximab | 2 | N | 260029374 | CHOP |
| 260009187 | 260005997 | 0 | null | Palliative (P) | 2013-08-09 | 2013-08-09 | R-EPOCH | 02 | null | 260029377 | RITUXIMAB |
| 260009188 | 260005997 | 1.65 | 81.9 | Not known (9) | null | 2013-04-10 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | 260029377 | FLUOROURACIL |
| 260009189 | 260005998 | 1.67 | 62.5 | Palliative (P) | 2018-07-04 | 2018-07-16 | Hydroxycarbamide | N | N | 260029379 | CHLORAMBUCIL |
| 260009190 | 260005998 | 1.73 | 90.4 | Curative (C) | 2014-02-22 | 2014-03-12 | Rituximab (Maintenance) | N | 2 | 260029379 | RITUXIMAB |
| 260009191 | 260005999 | 1.53 | 79 | Curative (C) | 2015-02-09 | 2015-02-11 | Hydroxycarbamide | N | N | 260029382 | CISPLATIN |
| 260009192 | 260005999 | null | 58 | Unknown (U) | null | 2017-03-29 | CHLORAMBUCIL + RITUXIMAB | N | N | 260029382 | RITUXIMAB |
| 260009193 | 260006000 | null | 77.1 | Disease modification (D) | 2017-09-14 | 2017-09-21 | null | N | N | 260029384 | CISPLATIN + GEMCITABINE |
| 260009194 | 260006000 | 1.74 | 52.7 | Palliative (P) | 2018-06-09 | 2018-06-16 | Rituximab | N | N | 260029384 | BENDAMUSTINE |
| 260009195 | 260006000 | 1.81 | 47.9 | Curative (C) | 2014-02-08 | 2014-02-28 | Bendamustine +/- Prednisolone | N | N | 260029384 | RITUXIMAB |
| 260009196 | 260017431 | 1.63 | 78.1 | Palliative (P) | 2015-09-07 | 2015-09-10 | Rituximab | N | N | 260029389 | CHOP |
| 260009197 | 260017431 | null | -1 | Disease modification (D) | 2018-01-29 | 2018-02-10 | CISPLATIN + ETOPOSIDE | N | N | 260029389 | EP |
| 260009198 | 260017431 | 1.6 | 101.4 | Adjuvant (A) | null | 2014-04-24 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260029389 | CHLORAMBUCIL + RITUXIMAB |
| 260009199 | 260006001 | 1.66 | null | Adjuvant (A) | 2017-06-30 | 2017-07-11 | R CODOX M | N | N | 260029398 | GALLIUM TRIAL |
| 260009200 | 260006002 | 1.66 | null | Disease modification (D) | 2015-03-03 | 2015-03-10 | CYCLO + RITUXIMAB + VINCRISTINE | N | N | 260029400 | OFATUMUMAB |
| 260009201 | 260006002 | 1.69 | 79 | Palliative (P) | 2013-11-21 | 2013-12-10 | Rituximab (Maintenance) | N | N | 260029400 | RITUXIMAB |
| 260009202 | 260006003 | null | 22 | null | null | 2016-10-24 | BENDAMUSTINE | null | null | 260029406 | CHOP |
| 260009203 | 260006003 | null | 63.2 | Disease modification (D) | 2013-07-18 | 2013-07-18 | Rituximab | 02 | N | 260029406 | PACIFICO TRIAL |
| 260009204 | 260006003 | 1.6 | 57.2 | Not known (9) | 2017-05-03 | 2017-05-03 | ESHAP R | N | N | 260029406 | RITUXIMAB |
| 260009205 | 260006003 | 1.87 | null | Disease modification (D) | 2016-11-19 | 2016-11-28 | Rituximab | 2 | N | 260029406 | ABVD |
| 260009206 | 260006003 | 1.77 | null | Palliative (P) | 2018-01-07 | 2018-01-07 | CHOP R + METHOTREXATE | null | N | 260029406 | RITUXIMAB |
| 260009207 | 260006003 | 1.73 | 104.2 | Curative (C) | 2014-04-24 | 2014-05-04 | CHLORAMBUCIL + RITUXIMAB | N | N | 260029406 | CYCLOPHOSPHAMIDE |
| 260009208 | 260006004 | 1.81 | 91 | Palliative (P) | 2014-10-24 | 2014-10-29 | R ABVD | 2 | N | 260029421 | RITUXIMAB |
| 260009209 | 260012185 | 1.71 | null | Curative (C) | 2015-04-17 | 2015-04-17 | Bendamustine +/- Prednisolone | Y | N | 260029422 | RITUXIMAB |
| 260009210 | 260006005 | 1.56 | 69 | Curative (C) | 2014-04-08 | 2014-04-22 | IVAC | N | N | 260029426 | RITUXIMAB |
| 260009211 | 260006005 | 1.71 | 63 | Curative (C) | 2014-03-08 | 2014-03-08 | Bendamustine +/- Prednisolone | 02 | N | 260029426 | RITUXIMAB |
| 260009212 | 260015618 | 0 | null | Palliative (P) | 2016-12-14 | 2016-12-20 | CARBOPLATIN + ETOPOSIDE | N | N | 260029428 | CISPLATIN + ETOPOSIDE |
| 260009213 | 260015618 | 1.51 | 98 | Curative (C) | 2016-12-26 | 2016-12-28 | Chlorambucil | N | N | 260029428 | RITUXIMAB |
| 260009214 | 260015618 | 1.77 | null | Not known (9) | 2015-06-19 | 2015-06-25 | Rituximab | 2 | N | 260029428 | CAPECITABINE + CISPLATIN |
| 260009215 | 260015618 | 1.86 | null | Palliative (P) | 2016-08-06 | 2016-08-07 | Rituximab | 2 | N | 260029428 | BEVACIZUMAB |
| 260009216 | 260006006 | 1.6 | 92.6 | Curative (C) | 2017-01-30 | 2017-02-16 | Rituximab | N | N | 260029440 | CODOX M |
| 260009217 | 260006006 | 1.82 | 81.45 | Radical (R) | 2016-07-26 | 2016-08-11 | EP | N | N | 260029440 | RITUXIMAB |
| 260009218 | 260006007 | 1.86 | 55 | null | 2017-06-24 | 2017-07-02 | Rituximab | 02 | null | 260029443 | BENDAMUSTINE |
| 260009219 | 260006008 | null | null | Curative (C) | null | 2018-02-18 | Rituximab | N | N | 260029444 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260009220 | 260006009 | 1.59 | 54.1 | Palliative (P) | 2016-06-15 | 2016-06-28 | Cisplatin 7 day | N | N | 260029446 | RITUXIMAB |
| 260009221 | 260006010 | 1.77 | 72.3 | Palliative (P) | 2014-05-13 | 2014-05-31 | Rituximab (Maintenance) | N | N | 260029447 | CISPLATIN + ETOPOSIDE |
| 260009222 | 260006010 | 1.74 | 64 | Adjuvant (A) | 2014-05-23 | 2014-05-25 | Rituximab | N | N | 260029447 | BENDAMUSTINE |
| 260009223 | 260006010 | 1.64 | 65.6 | Curative (C) | 2018-09-04 | 2018-09-08 | Rituximab | 1 | N | 260029447 | GALLIUM TRIAL |
| 260009224 | 260006010 | 1.78 | 63.9 | Curative (C) | 2015-05-14 | 2015-05-25 | Rituximab | Y | Y | 260029447 | ESHAP |
| 260009225 | 260006010 | 0 | 47 | Adjuvant (A) | 2014-09-09 | 2014-10-15 | FCR | N | N | 260029447 | RITUXIMAB |
| 260009226 | 260006011 | 1.74 | 87 | null | 2016-04-04 | 2016-04-06 | Cyclophosphamide High Dose | null | null | 260029464 | CAPECITABINE + IRINOTECAN |
| 260009227 | 260012189 | 1.67 | null | Curative (C) | 2014-07-02 | 2014-07-06 | Chlorambucil + Pred + Rituximab | Y | N | 260029465 | RITUXIMAB |
| 260009228 | 260006012 | null | 85.5 | Curative (C) | null | 2016-11-12 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + ETOPOSIDE + VINCRISTINE | null | null | 260029466 | TRIAL |
| 260009229 | 260006012 | 1.75 | 79.9 | Palliative (P) | 2015-11-23 | 2015-12-07 | Rituximab (SUBCUTANEOUS Maintenance) | Y | N | 260029466 | IVE-R |
| 260009230 | 260006012 | 1.61 | 71 | Curative (C) | 2014-02-08 | 2014-02-15 | CTD | 02 | null | 260029466 | CHOP |
| 260009231 | 260006013 | 1.73 | 88 | null | 2015-06-12 | 2015-07-02 | Chlorambucil | N | null | 260029474 | CHLORAMBUCIL + RITUXIMAB |
| 260009232 | 260006013 | 1.64 | 65.7 | Disease modification (D) | 2013-11-23 | 2013-12-08 | AML17 TRIAL | 02 | N | 260029474 | BENDAMUSTINE |
| 260009233 | 260006014 | 1.68 | 76.6 | Not known (9) | 2013-03-27 | 2013-03-28 | Rituximab | N | null | 260029477 | RITUXIMAB |